mainadimage
An Echelon Media Company
Sunday July 25th, 2021
Health

Sri Lanka’s COVID-19 third wave claims over 3,200 lives in just three months

ECONOMYNEXT – With 3,218 deaths and 187,076 cases in the span of just three months, the third wave of COVID-19 in Sri Lanka has been devastating to say the least.

To put the third wave – which officially began on April 15 this year – in perspective, until its arrival, Sri Lanka’s COVID-19 death toll stood at 609.

The following is a breakdown of the numbers so far, as recorded by the health ministry’s epidemiology unit:

Of the 187,076 cases of the third wave, 177,627 were detected in the community, while 6,430 tested positive for the virus at Sri Lanka’s prisons while 3,019 were returnees from abroad.

Total COVID-19 infections in the country so as of July 19 is 286,418.

So far 261,847 have returned home upon recovery, though not much research has been done in Sri Lanka on the impact of ‘long COVID’.

At the time of writing, 20,744 are still receiving treatment. Of these:

  • 6,103 patients are receiving treatment in 86 government hospitals dedicated to COVID-19
  • 9,515 patients are receiving treatment at 57 intermediate treatment centres
  • 3,395 patients are receiving treatment at 21 paid intermediate treatments centres

Colombo district has recorded the highest number of cases so far

Here’s a district-level breakdown of the numbers so far:

  • Colombo: 66,400
  • Gampaha: 51,110
  • Kalutara: 28,201
  • Kandy: 13,456
  • Kurunegala: 13,045
  • Galle: 12,968
  • Ratnapura: 12,229
  • Nuwara Eliya: 7,324
  • Jaffna: 6,846
  • Matara: 6,498
  • Kegalle: 6,210
  • Matale: 5,512
  • Batticaloa: 5,419
  • Badulla: 5,384
  • Ampara: 5,106
  • Anuradhapura: 4,885
  • Puttalam: 4,737
  • Hambantota: 3,619
  • Trincomalee: 3,551
  • Polannaruwa: 3,367
  • Monaragala: 2,705
  • Vavuniya: 1,653
  • Kilonochchi: 1,584
  • Mullaitivu: 1,375
  • Mannar: 1,343

As of July 19, 4,923 were in 70 government and paid quarantine facilities.

Authorities have failed to surpass the 15,000 mark with PCR testing since July 05.

According to the Health Promotion Bureau, only 10,436 PCR tests and 3,887 rapid antigen tests were performed on Tuesday (20).

On the vaccination front, Sri Lanka is making progress, with 5,879,973 receiving at least one dose of one of five vaccines being rolled out in the country. As of July 20, 1,697,561 have received their second dose.

Sri Lanka uses the AstraZeneca Covishiled, Sinopharm, Sputnik V, Pfizer-BioNtech and Moderna COVID-19 vaccines.

As of July 20, 4,635,090 have received the first dose of Sinopharm, while 1,297,337 have received the second. The first dose of Sputnik V has been administrated to 159,081 and 14,464 have received the second dose of the Russian vaccine.

The first dose of the Pfizer and Moderna have been administrated to 46,910 and 107,787 respectively.

As per the State Ministry of Production, Supply and Regulation of Pharmaceuticals Sri Lanka has received 180,000 doses of Sputnik  V, 115,830 doses of Pfizer, 7,100,000 of Sinopharm and 1,500,100 of Moderna so far. According to the ministry, Sri Lanka has acquired a total of 10,159,930 doses of vaccines so far.

Sri Lanka is aiming a target of 13 million doses of Sputnik V, five million of doses of Pfizer, 14 million doses of Sinopharm vaccine in the future, the ministry said.

President Gotabhaya Rajapksa has ordered the inoculation of people over 30 years of age in the Western Province by the end of July.

State Minister of Production, Supply and Regulation of Pharmaceuticals Chann Jayasumana told media on July 19 vaccination of Sri Lankans over 18 will likely begin in September and that officials are also looking at the possibility of giving the jab to children above 12 as well.  (Colombo/Jul21/2021)

Tags:

Leave a Comment

Your email address will not be published. Required fields are marked *

Your email address will not be published. Required fields are marked *

Comments

Leave a Comment

Your email address will not be published. Required fields are marked *

Your email address will not be published. Required fields are marked *